• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Personalized Medicine is the Future

    Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.

  2. Five Growth Stories (or Lack Thereof)

    Markets editor Jeremy Glaser considers growth hopes and woes at J.C. Penney, Facebook, Greece, and more.

  3. Smooth Sailing or Stormy Seas?

    Morningstar markets editor Jeremy Glaser examines what the week's headlines suggest about employment, China, autos, and more.

  4. 5 Disappointments for Investors

    High hopes for Greece, Fed action, Microsoft's new tablet, and J.C. Penney's turnaround topped the letdown list this week.

  1. Truth vs. Ignorance—The Impactful Investment Manager of Tomorrow

     

  2. Morgan Stanley Seeks Fed Approval for Buying Rest of Brokerage

    Morgan Stanley is seeking Federal Reserve approval to buy the remaining 35 percent of its brokerage joint venture with Citigroup Inc. this year.

  3. Financials: What’s in Store for Goldman Sachs, JP Morgan, Bank of America and Citigroup?

     

  4. Citigroup to Sell Delaware Trust Company to Reliance Financial

    The transaction involves approximately 3,000 accounts and $1.7 billion in assets under administration, which represent non-target business for Citi Private Bank's trust business.

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.